Our history

FB Dermatology is exploring the use of FLE with a view to developing more non-invasive treatments for a number of skin conditions.

2011

First Fluorescent Light Energy biomodulation patent issued.

2013

Highly efficacious clinical results using FLE for moderate to severe acne vulgaris

Received CE mark approval in Europe for Kleresca® and the use of FLE in Dermatology and Aesthetic Medicine

2014

Received CE mark approval in Europe for LumiHeal™ and the use of FLE for the treatment of chronic and acute wounds.

2016

Initial launch of Kleresca® in Europe and Australia.

2017

Initial launch of LumiHeal™ in Italy

Today

Today, our company is present all over Europe as well as Israel, Australia and New Zealand.

We are committed to expand the use of FLE all over the word as well as to launch new cutting-edge complementary products.

Footprint

Do you need more information?

Fill in the form below

I agree to the Privacy policy and I consent to the processing and storage of my personal data*.
I agree to be contacted for marketing and commercial purposes*

© Copyright 2020 FB DERMATOLOGY s.r.l. - VAT: IT02259770440 - All rights reserved
Via San Giovanni Scafa - San Benedetto del Tronto - 63074 (AP) - Italia - Web Design: TiME Agency